Case Studies

Lead Optimisation Project
  • US clinical stage biopharmaceutical company focused on discovering, developing and
    commercializing innovative therapeutics in immune disease
  • The company has in-house medicinal chemistry and in vitro biology, but due to space constraints cannot add extra in-house resource, so Sygnature is providing additional external medicinal chemistry FTEs
  • This is an ongoing five-year collaboration with Sygnature’s medicinal chemists who receive all biological data and provide considerable intellectual input into the project
  • We have developed a close working relationship, despite the difference in time zones, with weekly teleconferences and face-to-face meetings, when required
    – The company is being purchased in a multi-billion US dollar deal

Copyright © 2018 Sygnature Discovery

Website built by AtomicMedia - Design by Freestyle.